EFG Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$13.8M Buy
18,051
+3,113
+21% +$2.32M 1.78% 6
2025
Q2
$11.6M Buy
14,938
+3,177
+27% +$2.47M 1.64% 6
2025
Q1
$9.71M Buy
11,761
+8,397
+250% +$6.99M 1.61% 7
2024
Q4
$2.6M Buy
+3,364
New +$2.79M 0.35% 127
2023
Q4
Sell
-3,327
Closed -$1.79M 195
2023
Q3
$1.79M Buy
3,327
+161
+5% +$83K 0.42% 81
2023
Q2
$1.48M Buy
+3,166
New +$1.33M 0.32% 109
2023
Q1
Sell
-7,435
Closed -$2.73M 190
2022
Q4
$2.73M Sell
7,435
-145
-2% -$51.4K 0.61% 59
2022
Q3
$2.45M Sell
7,580
-615
-8% -$195K 0.57% 57
2022
Q2
$2.66M Buy
8,195
+1,121
+16% +$336K 0.56% 61
2022
Q1
$2.03M Buy
+7,074
New +$1.82M 0.3% 107

Other funds holding LLY

EFG Asset Management's LLY Position: Q3 2025 in Review

EFG Asset Management increased its Eli Lilly (LLY) stake by 21% in Q3 2025, buying an estimated $2.32M and bringing the position to 18,051 shares worth $13.8M. The position accounts for 1.78% of the portfolio, ranked #6.

EFG Asset Management first reported a position in LLY in Q1 2022 and has held it in 10 quarters since. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • EFG Asset Management held 18,051 shares of Eli Lilly worth $13.8M as of Q3 2025.
  • EFG Asset Management bought 3,113 Eli Lilly shares in Q3 2025, an estimated $2.32M.
  • Eli Lilly made up 1.78% of EFG Asset Management's portfolio in Q3 2025, its #6 holding.
  • EFG Asset Management first reported a position in Eli Lilly in Q1 2022 and has held it in 10 quarters since.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on EFG Asset Management's 13F filing for Q3 2025, filed 3 Nov 2025.